Fairvalue-Calculator Fairvalue-Calculator
EN DE

Alector, Inc (ALEC) Fair Value & Analysis

Healthcare · US · Market cap $173M

Price$1.83
Fair Value$1.24
Upside-32.2%
Quality95/100
Evidence: Low Range $0.9300 – $1.55

Fair value as of: Jun 24, 2026

Analysis

Alector, Inc (ALEC) currently trades at $1.83, while our model-based Fair Value estimate is $1.24 — implying the stock looks roughly 32.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson's disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer's disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson's disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elev…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Alector, Inc (ALEC) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $1.24 versus a price of $1.83 — about −32% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ALEC?
Our 21-model fair value for Alector, Inc is $1.24 (as of Jun 24, 2026), built from audited fundamentals. The current price is $1.83.
What is the quality score of ALEC?
Alector, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.